| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81K | — | +710.0% |
| R&D Expense | $5K | -92.6% | -99.5% |
| SG&A Expense | $1.0M | -19.6% | -18.8% |
| Operating Income | -$992K | +24.7% | +54.4% |
| Pre-tax Income | -$988K | +24.9% | +54.4% |
| Income Tax | $2K | +0.0% | +101.0% |
| Net Income | -$988K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.8M | -10.2% | +28.7% |
| Accounts Receivable | $725K | — | — |
| Inventory | $1.4M | — | — |
| Current Assets | $6.4M | +47.0% | +31.2% |
| Total Assets | $8.2M | +85.4% | +51.6% |
| Current Liabilities | $1.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | — |
| Financing Cash Flow | $5.5M | — | — |
| +49.5% |
| EPS (Basic) | -$1.31 | -33.7% | +97.0% |
| EPS (Diluted) | -$1.31 | -33.7% | +97.0% |
| +31.8% |
| -84.2% |
| Total Liabilities | $1.1M | +37.9% | -83.3% |
| Stockholders' Equity | $7.1M | +95.4% | +831.5% |